Altri SGPS reported a challenging first quarter of 2026, with severe storms in Portugal disrupting operations. EBITDA fell to EUR 5.4 million from EUR 18 million in Q1 2025, while net profit swung to a loss of EUR 7 million from a profit of EUR 8 million. Despite the results, the stock rose 3.07% to EUR 5.21, reflecting investor optimism about strategic initiatives.
The company maintains a solid balance sheet and focuses on diversification. The Caima Acetic Acid and Furfural Project is on track for completion by June 2026, and the Biotek dissolving pulp conversion is expected by end of 2026.
CEO José Pina stated: "Our strategic initiatives are progressing well, and we are confident in our ability to navigate these challenging times."
